Augmented Reduced-Intensity Regimen Does Not Improve Postallogeneic Transplant Outcomes in AML
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Augmented Reduced-Intensity Regimen Does Not Improve Postallogeneic Transplant Outcomes in Acute Myeloid Leukemia
J. Clin. Oncol 2020 Dec 29;[EPub Ahead of Print], C Craddock, A Jackson, J Loke, S Siddique, A Hodgkinson, J Mason, G Andrew, S Nagra, R Malladi, A Peniket, M Gilleece, R Salim, E Tholouli, V Potter, C Crawley, K Wheatley, R Protheroe, P Vyas, A Hunter, A Parker, K Wilson, J Pavlu, J Byrne, R Dillon, N Khan, N McCarthy, SD FreemanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.